Lebanon is the 2nd largest market in the number of studies representing 18% of the clinical research market in the Levant/GCC region, as of January 2024.
*clinicaltrials.gov/Jan2024
With 160+ studies since 2009, CD Log has doubled its business within the last 5 years and captured 27% of interventional drug studies running in Lebanon in 2024.
Local transport of biological samples within the Lebanese territory for clinical trials
Milan- Italy
Frozen Storage Available for (-25)-(-15)C
DTP deliveries ensured patients' treatment continuity, during the COVID-19 pandemic